Novartis AG – Filings and Transcripts

NYSE: NVS
Share price (4/2/26): $154.03
Market cap (4/2/26): $294 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022 – amended

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Bulto Carulla Victor

Tourmaline Bio Inc.

UBS AM, a Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC

News Filter

Material disclosure

Pursuant to the Requirements of the Securities Exchange Act of 1934, the Registrant Has Duly Caused This Report to Be Signed on Its Behalf by the Undersigned, Thereunto Duly Authorized

Delivered High Single-Digit Sales Growth, Achieved 40% Core Margin and Further Advanced the Pipeline in 2025

Receives FDA Approval for Itvisma®, the Only Gene Replacement Therapy for Children Two Years and Older, Teens, and Adults With Spinal Muscular Atrophy (SMA) Ad Hoc Announcement Pursuant to Art. 53 LR

Projects +5-6% Cc Sales CAGR 2025-2030, With Long-Term Growth Backed by 30+ Potential High-Value Pipeline Assets

Proxies Filter

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Other Filter

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012